Rural Health
Resources by Topic: Pharmacy and prescription drugs
MedPAC Report to the Congress: Medicare and the Health Care Delivery System, June 2025
Evaluates Medicare payment issues and provides recommendations to the U.S. Congress. Covers proposed reforms to the physician fee schedule updates and the accuracy of relative payment rates; supplemental benefits in Medicare Advantage; home healthcare use among Medicare Advantage enrollees; Part D prescription drug plans for beneficiaries in fee-for-service Medicare and Medicare Advantage; Medicare beneficiaries in nursing homes; the inclusion of rural providers in current Medicare fee-for-service quality reporting programs; and recommendations related to reducing beneficiary cost sharing for outpatient services at Critical Access Hospitals. Includes rural references throughout.
Additional links: Executive Summary
Date: 06/2025
Sponsoring organization: Medicare Payment Advisory Commission
view details
Evaluates Medicare payment issues and provides recommendations to the U.S. Congress. Covers proposed reforms to the physician fee schedule updates and the accuracy of relative payment rates; supplemental benefits in Medicare Advantage; home healthcare use among Medicare Advantage enrollees; Part D prescription drug plans for beneficiaries in fee-for-service Medicare and Medicare Advantage; Medicare beneficiaries in nursing homes; the inclusion of rural providers in current Medicare fee-for-service quality reporting programs; and recommendations related to reducing beneficiary cost sharing for outpatient services at Critical Access Hospitals. Includes rural references throughout.
Additional links: Executive Summary
Date: 06/2025
Sponsoring organization: Medicare Payment Advisory Commission
view details
Report to Congress on Medicaid and CHIP, June 2025
Semi-annual report to Congress from the Medicaid and CHIP Payment and Access Commission (MACPAC). Covers recommendations related to transitions from pediatric to adult care for Medicaid-covered children and youth with special health care needs (CYSHCN). Also discusses appropriate access to residential behavioral health treatment services for children, findings from MACPAC's analytic work on access to medications for opioid use disorder (MOUD) in Medicaid, an overview on the Program of All-Inclusive Care for the Elderly, and self-direction for Medicaid home- and community-based services. Includes rural references throughout.
Date: 06/2025
Sponsoring organization: Medicaid and CHIP Payment and Access Commission
view details
Semi-annual report to Congress from the Medicaid and CHIP Payment and Access Commission (MACPAC). Covers recommendations related to transitions from pediatric to adult care for Medicaid-covered children and youth with special health care needs (CYSHCN). Also discusses appropriate access to residential behavioral health treatment services for children, findings from MACPAC's analytic work on access to medications for opioid use disorder (MOUD) in Medicaid, an overview on the Program of All-Inclusive Care for the Elderly, and self-direction for Medicaid home- and community-based services. Includes rural references throughout.
Date: 06/2025
Sponsoring organization: Medicaid and CHIP Payment and Access Commission
view details
Congress Must Act to Bring Needed Reforms to the 340B Drug Pricing Program: Majority Staff Report
Presents findings from a U.S. Senate Committee on Health, Education, Labor & Pensions majority staff report on how covered entities generate and use revenue from the 340B Drug Pricing Program and how patients benefit from the program. Describes data and information collected from hospital covered entities, Bon Secours Mercy Health and Cleveland Clinic; Federally Qualified Health Center (FQHC) covered entities, Sun River Health and Yakima Valley Farm Workers Clinic; contract pharmacies, CVS Health and Walgreens; and drug manufacturers, Eli Lilly and Amgen. Includes rural references throughout.
Date: 04/2025
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Presents findings from a U.S. Senate Committee on Health, Education, Labor & Pensions majority staff report on how covered entities generate and use revenue from the 340B Drug Pricing Program and how patients benefit from the program. Describes data and information collected from hospital covered entities, Bon Secours Mercy Health and Cleveland Clinic; Federally Qualified Health Center (FQHC) covered entities, Sun River Health and Yakima Valley Farm Workers Clinic; contract pharmacies, CVS Health and Walgreens; and drug manufacturers, Eli Lilly and Amgen. Includes rural references throughout.
Date: 04/2025
Sponsoring organization: Senate Committee on Health, Education, Labor & Pensions
view details
Characteristics of Adults Age 18 and Older Who Took Prescription Medication for Depression: United States, 2023
Provides 2023 data on the characteristics of adults who took prescription medication for depression. Includes a breakdown by region and urbanization level, including nonmetropolitan, medium and small metropolitan, large fringe metropolitan, or large central metropolitan area.
Author(s): Nazik Elgaddal, Julie D. Weeks, Laryssa Mykyta
Date: 04/2025
Sponsoring organization: National Center for Health Statistics
view details
Provides 2023 data on the characteristics of adults who took prescription medication for depression. Includes a breakdown by region and urbanization level, including nonmetropolitan, medium and small metropolitan, large fringe metropolitan, or large central metropolitan area.
Author(s): Nazik Elgaddal, Julie D. Weeks, Laryssa Mykyta
Date: 04/2025
Sponsoring organization: National Center for Health Statistics
view details
April 2025 MedPAC Meeting Transcript
Transcript from the Medicare Payment Advisory Commission's (MedPAC) April 2025 meeting. Covers physician fee schedule updates and improving the accuracy of relative payment rates; structural differences between the stand-alone prescription drug plan (PDP) and Medicare Advantage–Prescription Drug plan (MA–PD) markets; the utilization and delivery of Medicare Advantage supplemental benefits; the effect of Medicare Advantage on rural hospitals; paying for software technologies in Medicare; access to hospice and certain services under the hospice benefit for beneficiaries with end-stage renal disease and beneficiaries with cancer; and regulations, star ratings, and fee-for-service Medicare policies aimed at improving nursing home quality.
Additional links: Exploring the Effect of Medicare Advantage on Rural Hospitals
Date: 04/2025
Sponsoring organization: Medicare Payment Advisory Commission
view details
Transcript from the Medicare Payment Advisory Commission's (MedPAC) April 2025 meeting. Covers physician fee schedule updates and improving the accuracy of relative payment rates; structural differences between the stand-alone prescription drug plan (PDP) and Medicare Advantage–Prescription Drug plan (MA–PD) markets; the utilization and delivery of Medicare Advantage supplemental benefits; the effect of Medicare Advantage on rural hospitals; paying for software technologies in Medicare; access to hospice and certain services under the hospice benefit for beneficiaries with end-stage renal disease and beneficiaries with cancer; and regulations, star ratings, and fee-for-service Medicare policies aimed at improving nursing home quality.
Additional links: Exploring the Effect of Medicare Advantage on Rural Hospitals
Date: 04/2025
Sponsoring organization: Medicare Payment Advisory Commission
view details
Screening and Referral Programs for Diabetes and Cardiovascular Disease: Can Community Pharmacists Bridge the Care Gap?
Examines the community-based valued-driven care initiative (CVCI) in community pharmacies to evaluate its effectiveness related to screening and referral (S&R) to treat cardiovascular disease (CVD) and diabetes mellitus (DM). Analyzes patient demographics and success rates of CVD and DM S&R in 6 community pharmacies, with both rural and urban locations represented.
Author(s): Melanie Livet, Amber Watson, Shweta Pathak, et al.
Citation: Exploratory Research in Clinical and Social Pharmacy, 17, 100539
Date: 03/2025
view details
Examines the community-based valued-driven care initiative (CVCI) in community pharmacies to evaluate its effectiveness related to screening and referral (S&R) to treat cardiovascular disease (CVD) and diabetes mellitus (DM). Analyzes patient demographics and success rates of CVD and DM S&R in 6 community pharmacies, with both rural and urban locations represented.
Author(s): Melanie Livet, Amber Watson, Shweta Pathak, et al.
Citation: Exploratory Research in Clinical and Social Pharmacy, 17, 100539
Date: 03/2025
view details
North Carolina Medication Assistance Program: 2024 Profile
Fact sheet on funding, performance measures, and economic impact of the North Carolina Medication Assistance Program. Includes a county-level map showing Medication Assistance Program sites as of state fiscal year 2024.
Date: 02/2025
Sponsoring organization: North Carolina Office of Rural Health
view details
Fact sheet on funding, performance measures, and economic impact of the North Carolina Medication Assistance Program. Includes a county-level map showing Medication Assistance Program sites as of state fiscal year 2024.
Date: 02/2025
Sponsoring organization: North Carolina Office of Rural Health
view details
Enhancing Rural Access to Medications for Opioid Use Disorder: Policy Brief and Recommendations to the Secretary
Provides an overview of issues related to opioid use disorder (OUD) in rural areas. Discusses access to medication for opioid use disorder (MOUD), MOUD workforce, telehealth to support access to MOUD, and Medicaid 1115 demonstrations that address OUD. Offers policy recommendations related to regulatory barriers, reimbursement flexibility, workforce, and service site expansion to increase access to MOUD in rural areas.
Date: 01/2025
Sponsoring organization: National Advisory Committee on Rural Health and Human Services
view details
Provides an overview of issues related to opioid use disorder (OUD) in rural areas. Discusses access to medication for opioid use disorder (MOUD), MOUD workforce, telehealth to support access to MOUD, and Medicaid 1115 demonstrations that address OUD. Offers policy recommendations related to regulatory barriers, reimbursement flexibility, workforce, and service site expansion to increase access to MOUD in rural areas.
Date: 01/2025
Sponsoring organization: National Advisory Committee on Rural Health and Human Services
view details
Assessing the Needs of Rural Families Affected by the Opioid Crisis: Issue Brief and Recommendations to the Secretary
Explores the considerations for addressing social determinants of health that influence opioid use disorder (OUD) and the role of community efforts in prevention, treatment, and recovery in rural areas, with a focus on prevention efforts in Las Vegas, New Mexico. Discusses youth and family prevention and well-being; stigma; adverse childhood experience; school-based health centers and youth and family resource centers; access to stable housing, food, and other social supports; the importance of trusted community resources for support; and workforce. Offers recommendations related to reducing stigma and promoting the enhanced utilization of the Community Services Block Grant (CSBG) to help rural communities address OUD and substance use disorders.
Date: 01/2025
Sponsoring organization: National Advisory Committee on Rural Health and Human Services
view details
Explores the considerations for addressing social determinants of health that influence opioid use disorder (OUD) and the role of community efforts in prevention, treatment, and recovery in rural areas, with a focus on prevention efforts in Las Vegas, New Mexico. Discusses youth and family prevention and well-being; stigma; adverse childhood experience; school-based health centers and youth and family resource centers; access to stable housing, food, and other social supports; the importance of trusted community resources for support; and workforce. Offers recommendations related to reducing stigma and promoting the enhanced utilization of the Community Services Block Grant (CSBG) to help rural communities address OUD and substance use disorders.
Date: 01/2025
Sponsoring organization: National Advisory Committee on Rural Health and Human Services
view details
Opioid Use Among Rural Medicare Beneficiaries
Examines trends in prescription opioid use among Medicare beneficiaries in rural areas, utilizing 2010-2017 Medicare Current Beneficiary Survey (MCBS) data. Provides data on receipt of opioid prescriptions among community-dwelling and facility-dwelling beneficiaries, associations between prescribing and chronic overlapping pain conditions (COPCs), and prescriptions exceeding CDC guidelines. Includes rural-urban comparisons.
Author(s): Yvonne Jonk, Heidi O'Connor, Karen Pearson, et al.
Date: 01/2025
Sponsoring organization: Maine Rural Health Research Center
view details
Examines trends in prescription opioid use among Medicare beneficiaries in rural areas, utilizing 2010-2017 Medicare Current Beneficiary Survey (MCBS) data. Provides data on receipt of opioid prescriptions among community-dwelling and facility-dwelling beneficiaries, associations between prescribing and chronic overlapping pain conditions (COPCs), and prescriptions exceeding CDC guidelines. Includes rural-urban comparisons.
Author(s): Yvonne Jonk, Heidi O'Connor, Karen Pearson, et al.
Date: 01/2025
Sponsoring organization: Maine Rural Health Research Center
view details